Results for "affordable"
HDA Statement on FDA Approval of Florida’s Prescription Drug Importation Plan
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released a statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and Cosmetic Act.
HDA Responds to the FTC/HHS Request for Information on Drug Shortages
The Healthcare Distribution Alliance (HDA) submitted comments to the Department of Health and Human Services (HHS) and the Federal Trade Commission (FTC) in response to the agencies’ joint Request for Information (RFI) on “Solicitation for Public Comment to Understand Lack of Competition and Contracting Practices that May be Contributing to Drug Shortages.”
HDA Statement on Proposed Tariffs of Pharmaceutical Products
HDA released a statement in response to President Donald J. Trump’s announcement on pledged tariffs for pharmaceuticals.
HDA Statement on “Most-Favored-Nation” Executive Order
HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.
Ariella Camera Joins HDA as Senior Director of Policy
The Healthcare Distribution Alliance (HDA) announces the addition of Ariella Camera as Senior Director of Policy. In this role, Ms. Camera will inform policy development on key issues impacting the healthcare distribution industry and report to HDA’s Chief Policy Officer, Dr. Nicolette Louissaint.